Richa Poddar is Chief Commercial Officer of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,508 shares of AGIO, which is worth approximately $468,620. The most recent transaction as insider was on Oct 17, 2022, when has been sold 1,485 shares (Common Stock) at a price of $27.48 per share, resulting in proceeds of $40,808. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.51K
0% 3M change
0% 12M change
Total Value Held $468,620

Richa Poddar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 17 2022
SELL
Payment of exercise price or tax liability
$40,808 $27.48 p/Share
1,485 Reduced 14.86%
8,508 Common Stock
Oct 15 2022
BUY
Exercise of conversion of derivative security
-
5,000 Added 33.35%
9,993 Common Stock
Feb 22 2022
SELL
Payment of exercise price or tax liability
$21,577 $29.08 p/Share
742 Reduced 14.32%
4,441 Common Stock
Feb 22 2022
BUY
Exercise of conversion of derivative security
-
658 Added 11.27%
5,183 Common Stock
Feb 18 2022
BUY
Exercise of conversion of derivative security
-
1,884 Added 29.4%
4,525 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$17,995 $30.5 p/Share
590 Reduced 18.26%
2,641 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
-
1,738 Added 34.98%
3,231 Common Stock
Feb 10 2022
SELL
Payment of exercise price or tax liability
$22,787 $31.43 p/Share
725 Reduced 32.69%
1,493 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
-
2,068 Added 48.25%
2,218 Common Stock
RP

Richa Poddar

Chief Commercial Officer
Cambridge, MA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO